72.55CHF-5.60%Mkt Cap: 5.44B CHFP/E: 36.64Last update: 2026-06-01
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, …
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap5.44B CHF
Enterprise Value5.79B CHF
Revenue (TTM)695.07M CHF
Gross Profit199.73M CHF
Net Income (TTM)148.79M CHF
Revenue/Share9.272 CHF
Last Price72.55 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.1K
CountryCH
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)36.64
P/E (Forward)25.41
PEG0.61
EV/EBITDA27.46
EV/Revenue8.33
P/S8.29
P/B3.95
EPS (TTM)1.98
EPS (Forward)3.02
52W Range
48.5269% of range83.25
52W High83.25 CHF
52W Low48.52 CHF
Profitability
Gross Margin28.74%
Oper. Margin26.27%
EBITDA Margin30.32%
Profit Margin21.41%
ROE10.20%
ROA7.06%
Growth
Revenue Growth4.70%
Earnings Growth16.60%
Cash Flow & Leverage
Operating CF271.57M CHF
CapEx (TTM)329.40M CHF
FCF Margin-10.90%
FCF Yield-1.39%
Net Debt29.28M CHF
Net Debt/EBITDA0.14
Balance Sheet
Debt/Equity4.13
Current Ratio1.79
Quick Ratio0.54
Book Value/Sh19.46 CHF
Cash/Share0.4140 CHF
Dividends
Fwd Div Rate0.9000 CHF
Trail. Div Rate0.9000 CHF
Div. Yield1.11%
5Y Avg Yield1.03%
Payout Ratio42.93%
Ex-Div DateMay 4, 2026
Pay DateMay 7, 2025
Splits
Last Split5:1
Split DateMay 5, 2022
Analyst Consensus
Rating—
Target (Mean)78.80 CHF
Target Range46.00 CHF – 110.00 CHF
# Analysts10
Ownership
Shares Out.74.94M
Float74.74M
Insiders0.25%
Institutions82.44%
Technical
SMA 5071.06 (+2.1%)
SMA 20062.59 (+15.9%)
Beta0.78
S&P 52W Chg27.70%
Avg Vol (30d)144.53K
Avg Vol (10d)146.39K
Technical Indicators
RSI (14)54.0
MACD2.5139
MACD Signal2.7821
MACD Hist.-0.2682
BB Upper84.20 CHF
BB Middle77.30 CHF
BB Lower70.39 CHF
BB Width17.87%
ATR (14)3.012 CHF
Vol Ratio (20d)2.95x